Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Exozymes Inc.

NASDAQ: EXOZ · Life Sciences · 4 alerts · CIK 2010788

Share price
$3.99Close, Nov 16
Market cap
$37.7M
Shares outstanding
9.44MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Exozymes Inc. filings on SEC EDGAR ↗

3:59 PM ET 10-Q
Financial Results

Exozymes Q3 2026 Results: Net Loss of $2.24M, Loss Narrows

EXOZYMES INC. reported a net loss of $7.49 million for the nine months ended September 30, 2026, compared to a $6.50 million loss in the prior year. The company remains in a development stage with no operating income, primarily funded by a public offering and registered direct offering that raised approximately $5.86 million in net proceeds during the period.

Key figure
Net loss $2.24M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.